ID3 MEDICAL
ActiveSummary
ID3 MEDICAL has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €269,159 and a net result of €233,425. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 69% of 13,741 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 13-11-2013 Normal situation
- Registered office
- 99 active companies are registered at this address 5 started in the 12 months before. Source: KBO register, as of 2 November 2026.
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460and 3 others
- Joint committee
- 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
- Establishment unit
- 2.224.858.514 1082 Sint-Agatha-Berchem, since 13-11-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 04-12-2025
Board and ownership
- M-CONCEPTSDirector · since 08-11-2013 · permanent representative MAENE Lieven
- PodimmedDirector · since 08-11-2013 · permanent representative DELOOSE Koen
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €416,264
- ▲ 122%
- Turnover
- ≈ €1.8m
- estimated
- Profit
- €233,425
- ▲ 40×
- Equity
- €269,159
- ▲ 98.3%
- Total assets
- €422,491
- ▲ 78.8%
- Employees on 31-12-2025
- 2
- ▼ 33.3%
Score breakdownlowers riskLiquidity: current ratio 2.75, cash €85,388Founded in 2013Equity €269,159 (63.7% of total assets)Figures for financial year 2025 (filed on 01-07-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 70% of them on solvency, 65% on liquidity, 95% on profitability and 93% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 8 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Resignations: PODIMMED (director) and M-CONCEPTS (director)Reappointments: PODIMMED (director) and M-CONCEPTS (director) · Permanent representatives: DELOOSE Koen and MAENE Lieven
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as ID3 MEDICAL: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €319,000 and €743,000, founded between 2011 and 2014.
| Company | Total assets | Gross margin |
|---|---|---|
| ID3 MEDICAL Sint-Agatha-Berchem | €422,491 | €416,264 |
| OTC DIFFUSION Sint-Gillis (bij-Brussel) | €318,948 | €395,048 |
| Advanz Pharma Belgium Sint-Joost-ten-Node | €365,371 | €288,375 |
| MEDITOR BENELUX Brussel | €735,858 | €496,920 |
| ALEXION SERVICES EUROPE Brussel | €742,735 | €465,288 |
| HOSPINOVA Eghezée | €509,654 | €284,946 |
| STYLEPHARMA Waterloo | €503,082 | €237,368 |
Key facts about ID3 MEDICAL
- What is the company number of ID3 MEDICAL?
- The company number of ID3 MEDICAL is 0541.834.476. The VAT number is the same number with BE in front: BE 0541.834.476.
- Where is ID3 MEDICAL based?
- The registered office is at Keizer Karellaan 584, 1082 Sint-Agatha-Berchem.Company details
- What does ID3 MEDICAL do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of ID3 MEDICAL?
- The legal form of ID3 MEDICAL is Private limited company (BV).
- When was ID3 MEDICAL founded?
- ID3 MEDICAL was founded on 13-11-2013.
- Is ID3 MEDICAL still active?
- Yes, ID3 MEDICAL is an active enterprise in the KBO register.
- How many employees does ID3 MEDICAL have?
- ID3 MEDICAL had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does ID3 MEDICAL fall under?
- In its 2025 annual accounts, ID3 MEDICAL states joint committee 200 (Aanvullend Paritair Comité voor de bedienden).
- What is the turnover of ID3 MEDICAL?
- The turnover in financial year 2025 is ≈ €1.8m. This figure is estimated from the gross margin of €416,264 and 38 comparable companies (NACE 464). It probably lies between €1.4m and €2.9m.
- Is ID3 MEDICAL profitable?
- In financial year 2025, ID3 MEDICAL made a profit of €233,425.
- Where can I find the annual accounts of ID3 MEDICAL?
- ID3 MEDICAL filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ID3 MEDICAL due?
- ID3 MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.